To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Penn State to lead new international Center Of Excellence for malaria research
07-16-2010: A researcher in Penn State's College of Agricultural Sciences will lead a seven-year, $14.5 million project to fight malaria in Southeast Asia. Liwang Cui, professor of entomology, is the principal investigator for the Southeast Asia Malaria Research Center, one of 10 International Centers of Excellence for Malaria Research announced by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
The 10 new centers will address research needs in regions where malaria is endemic, including parts of Africa, Asia, the Pacific Islands and Latin America. The Southeast Asia center will be a collaborative effort among Penn State, the University of California-Irvine and several institutions in China, Thailand and Myanmar.
"Southeast Asia accounts for 30 percent of global malaria morbidity and 8 percent of global mortality," Cui said. "We will build an international malaria center in this region that brings together diverse expertise from outstanding institutions to address urgent problems relevant to both regional and global malaria control."
Cui noted that various factors make malaria control a particular challenge in the region.
"Different forms of the malaria parasite in Southeast Asia are carried by different vectors, each requiring different treatment," he said. "This is magnified by the limited scientific knowledge on the complex interaction between the human host, mosquito vectors and the parasite.
"There also are issues related to emerging drug resistance in Plasmodium falciparum, which causes the most serious form of the disease, as well as problems with fake and counterfeit drugs circulating in the region," he explained. "In addition, political instability and transmigration along border areas pose special challenges in disease surveillance, diagnosis, treatment and control."
The center will undertake scientific research under four project areas:
1. "Malaria epidemiology in Southeast Asia: inter- and intra-country dynamics" will develop and evaluate integrated malaria-control strategies in multiple sites with varying epidemiological conditions.
2. "The malaria vectorial system and new vector-control tools in Southeast Asia" aims to understand the ecology of malaria vectors in the region and to develop innovative malaria-transmission surveillance and control tools.
3. "Antimalarial drug resistance in P. falciparum" is designed to determine the genetic mechanism of drug resistance in malaria parasite populations.
4. "Development of monoclonal antibody-based assays for detection and quantification of artemisinin derivatives" will develop methods for monitoring drug quality control.
"The participating institutions have internationally recognized investigators with a history of collaborations in malaria research and training," Cui said. "By selecting study sites in the most impoverished areas of Myanmar, China and Thailand, this consortium will shed new light on the urgent scientific questions surrounding regional and global malaria control."
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
- quality control
- Plasmodium falciparum
- infectious disease
- 1Glucose uptake relies on newly identified protein
- 2Drug companies enter Indonesia and the Philippines
- 3Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 4Nexia Biotechnologies to reorganize into oil and gas company
- 5Bayer acquires exclusive rights to Bioton’s insulin SciLin
- 6Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- 7AiCuris’ Novel HSV Compound AIC316 Shows Efficacy in Phase II
- 8Nomad Bioscience: new plant biotechnology company founded to focus on biomaterials and biopharmaceuticals
- 9Biotech companies in the future among top 10 drug sellers / winners & losers of the pharmaceutical industry in the next decade
- 10M&A Trends in Pharma-Biotech: An Analysis of a Business Model
- Children with rare, incurable brain disease improve after gene therapy
- First, do no harm: Study finds danger in standard treatment for a serious lu ...
- Scientists identify new target to battle rheumatoid arthritis
- Heparin-like compounds inhibit breast cancer metastasis to bone
- Tiny tool can play big role against tuberculosis
- Children with rare, incurable brain disease improve after gene therapy
- AB SCIEX Achieves ISO 13485 Certification for Manufacturing of LC/MS Systems
- First, do no harm: Study finds danger in standard treatment for a serious lung disease
- Scientists identify new target to battle rheumatoid arthritis
- Tiny tool can play big role against tuberculosis
- Commercial Production of Cellulosic Biofuel on Fast Track in China - - COFCO, Sinopec and Novozymes to Construct Biofuel Demonstration Facility by 2011
- OncoMethylome Sciences receives ISO 9001:2008 certification -
- Deinove signs a collaboration agreement with the Tereos group -
- BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet primary endpoint -
- Top Pharmaceutical and Biotech companies face slow down in sales growth over 2008–14 -
